Abstract
Ubiquitin-dependent proteolysis is a major mechanism that downregulates misfolded proteins or those that have finished a programmed task. In the last two decades, neddylation has emerged as a major regulatory pathway for ubiquitination. Central to the neddylation pathway is the amyloid precursor protein (APP)-binding protein APP-BP1, which together with Uba3, plays an analogous role to the ubiquitin-activating enzyme E1 in nedd8 activation. Activated nedd8 covalently modifies and activates a major class of ubiquitin ligases called Cullin-RING ligases (CRLs). New evidence suggests that neddylation also modifies Type-1 transmembrane receptors such as APP. Here we review the functions of neddylation and summarize evidence suggesting that dysfunction of neddylation is involved in Alzheimer's disease. © 2012 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd.
Author supplied keywords
Cite
CITATION STYLE
Chen, Y., Neve, R. L., & Liu, H. (2012). Neddylation dysfunction in Alzheimer’s disease. Journal of Cellular and Molecular Medicine, 16(11), 2583–2591. https://doi.org/10.1111/j.1582-4934.2012.01604.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.